YOLFTbeta
HealWELL AI Inc.

HealWELL AI Inc.

AIDX · TO · Healthcare / Medical Care Facilities

0.60CAD+0.02 (+3.45%)

Price History

Full chart

Market Stats

Previous Close0.58
Open0.58
Day Range0.58 – 0.60
52-Week Range0.58 – 1.61
Volume151.70K
Market Cap260.79M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.08
Dividend Yield0.00%
Beta-0.91
50-Day Avg0.744
200-Day Avg0.808

About

Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. James Lee
  • Employees570
  • Headquarters460 College Street, Toronto, ON, Canada, M6G 1A1, Canada
  • Websitehttps://www.healwell.ai

Leadership

  • Mr. James LeeChief Executive Officer
  • Dr. Alexander Julian DobranowskiFounder, President, MD & Director
  • Mr. Anthony LamChief Financial Officer
  • Mr. Brad PorterChief Commercial Officer & Director
  • Sean ChurchChief Financial Officer of Orion Health
  • Mark McAllister M.D.Chief Executive Officer of Verosource Solutions
  • Mr. Sacha GeraChief Operating Officer
  • Nolan ReedsVice President of Marketing & Communications
  • Mr. Blake CorbetSenior Vice President of Corporate Development
  • Ms. Madeline D. WalkerPresident of MCI Medical · b. 1947

Financials

Income Statement

Currency: CAD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue46.29M38.57M47.82M10.42M7.32M38.97M103.80M
Growth (%)--16.67%+23.96%-78.20%-29.81%+432.62%+166.35%
Cost of Revenue31.03M-25.65M32.81M6.71M6.06M21.66M63.42M
Gross Profit15.26M64.22M15.01M3.71M1.26M17.32M40.39M
Gross Margin32.97%166.49%31.39%35.59%17.18%44.43%38.91%
Operating Expense14.74M65.06M31.45M21.26M18.85M50.87M69.91M
Operating Income523.00K-842.00K-16.43M-17.55M-17.59M-33.55M-29.53M
Operating Margin1.13%-2.18%-34.37%-168.34%-240.43%-86.10%-28.44%
EBITDA3.76M2.11M-11.44M-13.94M-16.11M-18.42M-13.28M
EBITDA Margin8.12%5.48%-23.93%-133.71%-220.21%-47.26%-12.80%
Net Income-122.00K-1.03M-15.67M-21.09M-31.60M-26.29M-46.94M
Net Income Margin-0.26%-2.67%-32.77%-202.27%-431.83%-67.47%-45.22%
R&D--155.00K8.14M4.81M5.79M16.42M
R&D as % of Total Revenue--0.32%78.13%65.75%14.87%15.82%
Interest Expense536.00K497.00K535.00K618.00K1.58M2.61M10.16M
Interest Expense % of Total Revenue1.16%1.29%1.12%5.93%21.58%6.70%9.79%

Balance Sheet

Currency: CAD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets22.68M22.36M60.89M45.63M53.70M125.53M284.99M
Total Liabilities20.42M22.12M31.14M32.13M32.23M51.86M161.04M
Total Equity2.14M114.00K28.03M11.78M12.65M63.89M123.94M
Cash1.13M894.00K7.14M1.41M19.16M9.41M18.63M
Total Debt17.20M15.04M14.35M17.42M20.93M22.20M86.13M
Net Debt16.07M14.15M7.21M16.01M1.77M12.79M67.49M

Cash Flow

Currency: CAD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.21M4.22M-7.10M-8.35M-10.80M-22.62M-19.42M
Investing Cash Flow-122.00K-234.00K-8.64M-1.17M1.35M-15.37M-69.84M
Financing Cash Flow-2.89M-4.22M21.99M3.78M27.20M28.24M95.50M
Capital Expenditure122.00K234.00K2.37M1.15M66.00K1.31M737.00K
Free Cash Flow3.09M3.99M-9.47M-9.49M-10.86M-23.93M-20.16M
Dividends Paid-2.01M0116.00K-00
FCF to OCF96.20%94.46%133.36%113.76%100.61%105.80%103.80%
Dividend Paid to FCF-50.38%0.00%-1.22%-0.00%0.00%

Earnings

Report DateMay 13, 2021Aug 16, 2021Nov 15, 2021May 15, 2022Aug 15, 2022Nov 14, 2022Mar 30, 2023May 16, 2023Aug 15, 2023Nov 13, 2023Mar 28, 2024May 14, 2024Aug 12, 2024Nov 12, 2024Mar 25, 2025May 13, 2025Aug 13, 2025Nov 6, 2025Mar 19, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate-0.04-0.04-0.06-0.08-0.06-0.08-0.05----0.10-0.03-0.04-0.04-0.04-0.04-0.01-0.02-0.02-0.02-0.02-0.02
EPS Actual-0.05-0.05-0.11-0.09-0.08-0.18-0.07-0.14-0.18-0.14-0.08-0.06-0.06-0.06-0.20-0.04-0.03-0.05-0.01-0.02-0.03-
Surprise-25.00%-25.00%-83.33%-12.50%-33.33%-125.00%-40.00%---20.00%-100.00%-50.00%-50.00%-400.00%0.00%-200.00%-150.00%45.50%0.00%-50.00%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--After-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap260.79M
Enterprise Value298.81M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.03
Price / Book1.94
EPS-0.08
Book Value0.432
Revenue (TTM)128.74M
Gross Profit (TTM)71.56M
EBITDA-19.04M
Profit Margin-23.01%
Operating Margin-18.76%
Return on Equity-16.60%
Return on Assets-4.25%
Shares Outstanding303.55M
Shares Float167.93M
Beta-0.91
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%